Ruijs-Aalfs syndrome (RJALS) patient cells with monogenic and biallelic mutations in SPRTN are hypersensitive to DPC-inducing agents due to a defect in DNA replication fork progression and the inability to eliminate DPCs. The gene discussed is SPRTN; the disease is progeroid features-hepatocellular carcinoma predisposition syndrome.